ArticleAmerican journal of ophthalmology2026
The Developmental Landscape of Children With Uveal Coloboma and Its Relationship With Clinical Phenotype and Genetics.
Article in American journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeUveal coloboma may be an isolated finding or present as part of a syndrome, informed by systemic testing. Genetic testing may elucidate an underlying cause of disease. The likelihood of developmental delay in children with coloboma has not been well-studied. We examined the rates of developmental delay in coloboma patients with syndromic vs nonsyndromic presentations and with positive and negative molecular diagnoses.
methodsSeventy patients with coloboma underwent a battery of systemic testing, molecular diagnosis, and cognitive and/or adaptive behavioral testing between 2009 and 2023. Patients with ≥2 abnormal systemic findings, excluding ocular or developmental delay, were classified as syndromic. The associations between delay and syndromic diagnosis or positive molecular testing were analyzed with logistic regression.
resultsThe mean age of participants was 3.97 years. Twenty-three patients were syndromic. Causative variants were identified in 13 cases. Individuals with a syndromic presentation had greater odds of having or reporting developmental delay than those with a nonsyndromic presentation (odds ratio [95% confidence interval] = 4.81 [1.67, 14.69], Z = 2.85, P = .004). A syndromic diagnosis also increased the likelihood of having a solved genetic diagnosis (odds ratio [95% confidence interval] = 6.91 [1.94, 28.89], Z = 2.86, P = .004).
conclusionsSystemic findings are common in patients presenting with isolated coloboma, underscoring the need for deep phenotyping. In our study, a molecular diagnosis was obtained in only a minority, implying undiscovered genetic or environmental factors. Those patients with ≥2 systemic findings were more likely to be developmentally delayed and to have a positive molecular diagnosis. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.